株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓バイオマーカーの世界市場:2017年〜2021年

Global Cardiac Biomarkers Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 318286
出版日 ページ情報 英文 96 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
心臓バイオマーカーの世界市場:2017年〜2021年 Global Cardiac Biomarkers Market 2017-2021
出版日: 2017年10月10日 ページ情報: 英文 96 Pages
概要

世界の心臓バイオマーカー市場は、2017年から2021年の期間中にCAGRが12.97%成長する見込みとなっております。

当レポートでは、世界の心臓バイオマーカー市場について調査分析を行い、市場概要、セグメンテーション別考察、地域別考察、市場促進因子と課題、主要企業などについてまとめています。

第1章 エグゼクティブサマリー

第2章 レポートの範囲

第3章 市場調査の方法

第4章 イントロダクション

  • 市場動向の概略

第5章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 市場セグメンテーション:技術別

  • 市場概要
  • 従来の臨床検査
  • POC検査

第7章 市場セグメンテーション:製品別

  • 市場概要
  • 世界のトロポニン(cTnI, cTnT)測定市場
  • その他の測定市場
  • 世界のBNP/NT-proBNP測定市場
  • 世界のCK-MB測定市場
  • 世界のミオグロビン測定市場

第8章 市場セグメンテーション:エンドユーザー別

  • 市場概要
  • 病院・診療所
  • 臨床検査室

第9章 地域別セグメンテーション

  • 市場概要
  • 南北アメリカ
  • 欧州/中東/アフリカ
  • アジア太平洋地域

第10章 意思決定構造

第11章 市場成長促進因子と課題

第12章 市場動向

第13章 ベンダー情勢

  • 競合シナリオ
  • Abbott
  • Alere
  • F. Hoffmann-La Roche
  • 注目すべき企業
  • その他の主要ベンダー

第14章 付録

  • 略語一覧

図表

図表
  • Exhibit 01: Advantages associated with cardiac biomarkers
  • Exhibit 02: Market overview of global cardiac biomarkers market 2016
  • Exhibit 03: Global cardiac biomarkers market 2016-2021 ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Overview of global cardiac biomarkers market by technology 2016
  • Exhibit 06: Global cardiac biomarkers market by conventional laboratory testing 2016-2021 ($ millions)
  • Exhibit 07: Global cardiac biomarkers market by POC testing 2016-2021 ($ millions)
  • Exhibit 08: Overview of global cardiac biomarkers market by product 2016
  • Exhibit 09: Global troponin (cTnI, cTnT) assay market 2016-2021 ($ millions)
  • Exhibit 10: Global others assay market 2016-2021 ($ millions)
  • Exhibit 11: Global BNP & NT-proBNP assay market 2016-2021 ($ millions)
  • Exhibit 12: Global CK-MB assay market 2016-2021 ($ millions)
  • Exhibit 13: Global myoglobin assay market 2016-2021 ($ millions)
  • Exhibit 14: Overview and strategy of global cardiac biomarkers market by end-users 2016
  • Exhibit 15: Buying criteria of end-users in global cardiac biomarkers market 2016
  • Exhibit 16: Global cardiac biomarkers market by geography 2016 and 2021
  • Exhibit 17: Overview of cardiac biomarkers market in Americas
  • Exhibit 18: Cardiac biomarkers market in Americas 2016-2021 ($ millions)
  • Exhibit 19: Overview of cardiac biomarkers market in EMEA
  • Exhibit 20: Cardiac biomarkers market in EMEA 2016-2021 ($ millions)
  • Exhibit 21: Overview of cardiac biomarkers market in APAC
  • Exhibit 22: Cardiac biomarkers market in APAC 2016-2021 ($ millions)
  • Exhibit 23: Market analysis for the increasing cardiac diseases worldwide
  • Exhibit 24: Average cost of cardiac biomarkers
  • Exhibit 25: Clinical trials and their impact
  • Exhibit 26: Competitive structure analysis of global cardiac biomarkers market 2016
  • Exhibit 27: Market penetration of various cardiac biomarkers providers 2016
  • Exhibit 28: Strategic success factors of companies in global cardiac biomarkers market 2016
  • Exhibit 29: Abbott: Strength assessment
  • Exhibit 30: Abbott: Strategy assessment
  • Exhibit 31: Abbott: Opportunity assessment
  • Exhibit 32: Alere: Strength assessment
  • Exhibit 33: Alere: Strategy assessment
  • Exhibit 34: Alere: Opportunity assessment
  • Exhibit 35: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 38: Danaher: Company assessment
  • Exhibit 39: Siemens: Company assessment
目次
Product Code: IRTNTR14643

About Cardiac Biomarkers

Cardiac biomarkers are the substances used to detect the risk stratification of a patient with chest pain or suspected acute coronary syndrome (ACS). These biomarkers are released in blood when the heart is damaged or stressed. The tests that are carried out by introducing the cardiac biomarkers to the bloodstream help in determining the risks of associated heart conditions such as cardiac ischemia, ACS, myocardial infarction, and other associated heart diseases.

Technavio's analysts forecast the global cardiac biomarkers market to grow at a CAGR of 12.97% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac biomarkers market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Alere
  • F. Hoffmann-La Roche

Other Prominent Vendors

  • Advanced ImmunoChemical
  • AgPlus Diagnostics
  • AZSense
  • BD
  • BG Medicine
  • BioLegend
  • bioMerieux
  • Bio-Rad Laboratories
  • BODITECH MED
  • CAVADIS
  • Cisbio Bioassays
  • Creative Diagnostics
  • Critical Diagnostics
  • Cruinn Medical
  • DiaDexus
  • Enzo Life Sciences
  • Lepu Medical
  • LifeSign
  • LSI Medience
  • Merck
  • Monobind
  • Myriad RBM
  • NeoClone
  • NOWDiagnostics
  • Olink
  • Randox Laboratories
  • Response Biomedical
  • Signosis
  • Thermo Fisher Scientific
  • Tosoh Europe
  • Trinity Biotech
  • Trivitron Healthcare
  • Wondfo

Market driver

  • Increasing use of cardiac biomarkers
  • For a full, detailed list, view our report

Market challenge

  • Dominance of top vendors
  • For a full, detailed list, view our report

Market trend

  • Increased clinical trials
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by technology

  • Market overview
  • Conventional laboratory testing
  • POC testing

PART 07: Market segmentation by product

  • Market overview
  • Global troponin (cTnI, cTnT) assay market
  • Global others assay market
  • Global BNP & NT-proBNP assay market
  • Global CK-MB assay market
  • Global myoglobin assay market

PART 08: Market segmentation by end-user

  • Market overview
  • Hospitals and clinics
  • Diagnostic laboratories

PART 09: Geographical segmentation

  • Market overview
  • Cardiac biomarkers market in Americas
  • Cardiac biomarkers market in EMEA
  • Cardiac biomarkers market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Increased clinical trials
  • Increasing use of cardiac biomarkers in POC testing
  • Emerging cardiac biomarkers

PART 13: Vendor landscape

  • Competitive landscape
  • Abbott
  • Alere
  • F. Hoffmann-La Roche
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations
Back to Top